Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) (NCT06263426)

🧪 Interventions in This Study

• HIV D+/R+ (OTHER)
• HIV D-/R+ (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (18 Sites)

• University of Alabama at Birmingham — Birmingham, Alabama
• University of California, Davis — Sacramento, California
• University of California, San Diego — San Diego, California
• University of California, San Francisco — San Francisco, California
• Mayo Clinic Florida — Jacksonville, Florida
• Northwestern University — Chicago, Illinois
• Rush University Medical Center — Chicago, Illinois
• Ochsner Clinic Foundation — New Orleans, Louisiana
• Johns Hopkins University — Baltimore, Maryland
• Massachusetts General Hospital — Boston, Massachusetts
• Washington University St. Louis Barnes Jewish Hospital — St Louis, Missouri
• New York University — New York, New York
• Icahn School of Medicine at Mt. Sinai — New York, New York
• Columbia University — New York, New York
• Weill Cornell Medical Center — New York, New York
• University of Pennsylvania — Philadelphia, Pennsylvania
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
• Houston Methodist Research Institute — Houston, Texas

📞 Contact the Study Coordinator

Phone: (410) 614-6702

Email: cdurand2@jhmi.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hiv

• CD4 CAR+ ZFN-modified T Cells in HIV Therapy — Philadelphia, Pennsylvania
• Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP — Orlando, Florida
• Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients — Duarte, California
• Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity — Azua,
• Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV. — Birmingham, Alabama
• Wellness, Intervention Strategies and HIV Care — Oakland, California

Explore by condition: All Hiv clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.